Territory Stories

Northern Territory Government gazette : no. G16

Details:

Title

Northern Territory Government gazette : no. G16

Creator

Northern Territory Government

Collection

Northern Territory Government Gazette - G Series; E-Journals; PublicationNT; Northern Territory Government Gazette; General notice

Date

2014-04-23

Location

Darwin

Notes

Made available via the Publications (Legal Deposit) Act 2004 (NT).; This publication contains may contain links to external sites. These external sites may no longer be active.

Language

English

Subject

Gazettes; Politics and government; Government gazettes; Darwin (N.T.); Periodicals

Publisher name

Northern Territory Government

Place of publication

Darwin

Series

Northern Territory Government Gazette; General notice

Volume

no. G16, 23 April 2014

File type

application/pdf

ISSN

0157-8324

Use

Attribution International 4.0 (CC BY 4.0)

Copyright owner

Northern Territory Government

License

https://creativecommons.org/licenses/by/4.0/

Parent handle

https://hdl.handle.net/10070/250156

Citation address

https://hdl.handle.net/10070/559288

Page content

The Northern Territory Government Gazette No. G16, 23 April 2014 Page 3 (b) copies of the amendment, (Amendment No. 329), are available from the Offices of the Department of Lands, Planning and the Environment, Ground Floor, 16 Parap Road, Parap. Dated 1st April, 2014. P. G. CHANDLER Minister for Lands, Planning and the Environment 6/16 Medicines, Poisons and Therapeutic Goods Act RESTRICTED SCHEDULE 8 SUBSTANCES (a) I, STEVEN JAYE SKOV, Chief Health Officer, under section 246(1)(b) of the Medicines, Poisons and Therapeutic Goods Act, declare each Schedule 8 substance specified in the Schedule to be a restricted Schedule 8 substance. (b) In this instrument: restricted Schedule 8 substance, see section 5 of the Act. Schedule 8 substance, see section 7(2) of the Act. Dated 17th April, 2014. S. J. SKOV Chief Health Officer SCHEDULE Buprenorphine in tablet form 0.4mg, 2mg or 8mg for sublingual administration Buprenorphine 2mg/naloxone 0.5mg in film form for sublingual or buccal administration Buprenorphine 8mg/naloxone 2mg in film form for sublingual or buccal administration Methadone in liquid form at strength 5mg/mL for oral administration Methylphenidate all forms 7/16 Planning and the Environment, Ground Floor, Amhemica House, 16 Parap Road, Parap. Dated 8th April, 2014. P. G. CHANDLER Minister for Lands, Planning and the Environment 4/16 Medicines, Poisons and Therapeutic Goods Act CODE OF PRACTICE SCHEDULE 8 SUBSTANCES (a) I, STEVEN JAYE SKOV, Chief Health Officer, under section 244(4) of the Medicines, Poisons and Therapeutic Goods Act, give notice of the making of a code of practice in relation to Schedule 8 substances entitled Code of Practice Schedule 8 Substances dated 21 March 2014. (b) In this instrument: Schedule 8 substance, see section 7(2) of the Act. Dated 17th April, 2014. S. J. SKOV Chief Health Officer 5/16 Planning Act NOTICE OF MAKING OF AMENDMENT TO NT PLANNING SCHEME AMENDMENT No. 329 I, PETER GLEN CHANDLER, Minister for Lands, Planning and the Environment, under section 28(1) of the Planning Act, give notice that (a) I have, under section 25(2)(a) of the Act, amended the NT Planning Scheme by rezoning Lot 2796 Town of Katherine from Zone TC (Tourist Commercial) to Zone SD (Single Dwelling Residential) and Zone MD (Multiple Dwelling Residential); and


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.